1. Home
  2. KMDA vs MFH Comparison

KMDA vs MFH Comparison

Compare KMDA & MFH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KMDA
  • MFH
  • Stock Information
  • Founded
  • KMDA 1990
  • MFH 2011
  • Country
  • KMDA Israel
  • MFH United States
  • Employees
  • KMDA N/A
  • MFH N/A
  • Industry
  • KMDA Biotechnology: Pharmaceutical Preparations
  • MFH Finance: Consumer Services
  • Sector
  • KMDA Health Care
  • MFH Finance
  • Exchange
  • KMDA Nasdaq
  • MFH Nasdaq
  • Market Cap
  • KMDA 349.6M
  • MFH 394.2M
  • IPO Year
  • KMDA N/A
  • MFH N/A
  • Fundamental
  • Price
  • KMDA $5.80
  • MFH $6.81
  • Analyst Decision
  • KMDA Strong Buy
  • MFH
  • Analyst Count
  • KMDA 2
  • MFH 0
  • Target Price
  • KMDA $14.50
  • MFH N/A
  • AVG Volume (30 Days)
  • KMDA 31.3K
  • MFH 170.0K
  • Earning Date
  • KMDA 11-13-2024
  • MFH 12-27-2024
  • Dividend Yield
  • KMDA N/A
  • MFH N/A
  • EPS Growth
  • KMDA 124.29
  • MFH N/A
  • EPS
  • KMDA 0.27
  • MFH N/A
  • Revenue
  • KMDA $158,380,000.00
  • MFH $716,863.00
  • Revenue This Year
  • KMDA $15.38
  • MFH N/A
  • Revenue Next Year
  • KMDA $6.18
  • MFH N/A
  • P/E Ratio
  • KMDA $21.16
  • MFH N/A
  • Revenue Growth
  • KMDA 4.52
  • MFH 119.50
  • 52 Week Low
  • KMDA $4.74
  • MFH $1.03
  • 52 Week High
  • KMDA $6.53
  • MFH $8.07
  • Technical
  • Relative Strength Index (RSI)
  • KMDA 46.35
  • MFH 60.05
  • Support Level
  • KMDA $5.75
  • MFH $5.59
  • Resistance Level
  • KMDA $5.90
  • MFH $7.49
  • Average True Range (ATR)
  • KMDA 0.17
  • MFH 0.83
  • MACD
  • KMDA -0.04
  • MFH -0.11
  • Stochastic Oscillator
  • KMDA 20.66
  • MFH 59.16

About KMDA Kamada Ltd.

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, Proprietary Products segment and Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

About MFH Mercurity Fintech Holding Inc.

Mercurity Fintech Holding Inc is a digital fintech company powered by blockchain technology. The company's scope of business includes digital asset trading, asset digitization, cross-border remittance, and other services, providing compliant, professional, and efficient digital financial services to its customers. The group is also engaged in Bitcoin mining, digital currency investment, and trading, continuing its expansion to online and traditional brokerage services and other related fields.

Share on Social Networks: